Andrew J. Schwab

Insider Reports History

Entity
Individual
Location
C/O 5 Am Venture Management, Llc, 4 Embarcadero Center, Suite 3110, San Francisco, CA
Signature
/s/ Kaitlyn Arsenault, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew J. Schwab:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Skye Bioscience, Inc. Director Common Stock 8.17M $49.5M $6.06 Sep 13, 2024 By 5AM Ventures VII, L.P.
Skye Bioscience, Inc. Director Common Stock 1.68M $10.2M $6.06 Sep 13, 2024 By 5AM Ventures II, L.P.
Skye Bioscience, Inc. Director Common Stock 66.3K $402K $6.06 Sep 13, 2024 By 5AM Co-Investors II, L.P.
Pear Therapeutics, Inc. Director, 10%+ Owner Class A Common Stock 14.6M Dec 3, 2021 by 5AM Ventures IV, L.P.
Pear Therapeutics, Inc. Director, 10%+ Owner Class A Common Stock 3.37M Dec 3, 2021 by 5AM Opportunities I, L.P.
Camp4 Therapeutics Corp Director, 10%+ Owner Common Stock 2.63M Oct 15, 2024 Indirect
Pear Therapeutics, Inc. Director, 10%+ Owner Class A Common Stock 610K Dec 3, 2021 by 5AM Co-Investors IV, L.P.
Skye Bioscience, Inc. Director Stock Option (Right to Buy) 70K Oct 28, 2024 Direct
Enliven Therapeutics, Inc. Director, 10%+ Owner Stock Option (right to buy) 27.6K Feb 23, 2023 Direct
Camp4 Therapeutics Corp Director, 10%+ Owner Series A Prime Preferred Stock 0 Oct 15, 2024 Indirect
Camp4 Therapeutics Corp Director, 10%+ Owner Series B Preferred Stock 0 Oct 15, 2024 Indirect

Insider Reports Filed by Andrew J. Schwab

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SKYE Skye Bioscience, Inc. Oct 28, 2024 1 $0 4 Oct 30, 2024 Director
CAMP Camp4 Therapeutics Corp Oct 15, 2024 7 $10M 4 Oct 15, 2024 Director, 10%+ Owner
CAMP Camp4 Therapeutics Corp Oct 10, 2024 0 $0 3 Oct 10, 2024 Director, 10%+ Owner
SKYE Skye Bioscience, Inc. Sep 11, 2024 6 -$1.75M 4 Sep 13, 2024 Director, 10%+ Owner
SKYE Skye Bioscience, Inc. Mar 13, 2024 1 $4.5M 4 Mar 15, 2024 Director, 10%+ Owner
SKYE Skye Bioscience, Inc. Feb 29, 2024 1 $0 4 Mar 4, 2024 Director
SKYE Skye Bioscience, Inc. Jan 31, 2024 1 $12M 4 Feb 2, 2024 Director, 10%+ Owner
SKYE Skye Bioscience, Inc. Nov 6, 2023 1 $0 4 Nov 6, 2023 Director
SKYE Skye Bioscience, Inc. Aug 25, 2023 1 $0 4 Aug 29, 2023 Director
SKYE Skye Bioscience, Inc. Aug 18, 2023 6 $8.78M 4 Aug 22, 2023 Director, 10%+ Owner
SKYE Skye Bioscience, Inc. Aug 18, 2023 0 $0 3 Aug 22, 2023 Director, 10%+ Owner
ELVN Enliven Therapeutics, Inc. Feb 23, 2023 1 $0 4 Apr 6, 2023 Director, 10%+ Owner
ELVN Enliven Therapeutics, Inc. Feb 23, 2023 2 $0 4 Feb 27, 2023 Director
ELVN Enliven Therapeutics, Inc. Feb 23, 2023 0 $0 3 Feb 27, 2023 Director
PEARQ Pear Therapeutics, Inc. Dec 3, 2021 4 $2M 4 Dec 7, 2021 Director, 10%+ Owner
PEARQ Pear Therapeutics, Inc. Dec 3, 2021 0 $0 3 Dec 7, 2021 Director, 10%+ Owner